No New Regulations Needed For Third-Party Servicers Of Devices, FDA Says
Executive Summary
There is “not sufficient evidence” of a widespread public health concern relating to servicing of devices, including by third-parties, according to an FDA report; the agency sees no immediate needs to issue new regulatory requirements for the third-party servicers. The agency also intends to issue guidance to help clarify the difference between “servicing” and “remanufacturing."
You may also be interested in...
AdvaMed To FDA: Add 3rd-Party Servicers, Refurbishers To Quality Management System Reg
In comments to the US FDA on its proposed QMSR rule, AdvaMed says it’s concerned that third-party entities could fall prey to hackers because of the “current geopolitical environment that is fraught with cybersecurity threats.” In its own comments, the Association of Medical Device Service Organizations says the agency should remain hands-off.
Recent eMDR Change By FDA Asks Adverse Event Reporters About Third-Party Servicers
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Device Servicing And Remanufacturing: US FDA, Stakeholders Try To Draw Distinction
US FDA’s device center in concert with third-party servicers and original equipment manufacturers are working toward consensus on how to differentiate medtech "servicing" from "remanufacturing" activities. Progress was made at a recent workshop in laying out ways that better training and more data sharing will help.